Masimo Corporation (NASDAQ:MASI)‘s stock had its “buy” rating reaffirmed by research analysts at Stifel Nicolaus in a note issued to investors on Friday. They presently have a $108.00 price target on the medical equipment provider’s stock. Stifel Nicolaus’ price target indicates a potential upside of 25.58% from the stock’s previous close.

Other research analysts have also issued reports about the company. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a report on Monday, August 14th. Roth Capital lifted their target price on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. BidaskClub raised Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Zacks Investment Research raised Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a report on Thursday. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. Masimo Corporation currently has an average rating of “Hold” and an average target price of $97.17.

Shares of Masimo Corporation (NASDAQ:MASI) traded down $1.93 during midday trading on Friday, hitting $86.00. 261,418 shares of the company were exchanged, compared to its average volume of 384,306. The firm has a market cap of $4.37 billion, a P/E ratio of 32.37 and a beta of 0.75.

Masimo Corporation (NASDAQ:MASI) last released its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.53 by $0.17. The firm had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. Masimo Corporation’s revenue was up 15.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.52 earnings per share. sell-side analysts expect that Masimo Corporation will post 2.96 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/11/03/stifel-nicolaus-reiterates-buy-rating-for-masimo-corporation-masi.html.

In other Masimo Corporation news, EVP Yongsam Lee sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00. Following the completion of the sale, the executive vice president now directly owns 74,000 shares in the company, valued at approximately $6,651,860. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the sale, the director now owns 73,249 shares of the company’s stock, valued at $6,592,410. The disclosure for this sale can be found here. Insiders have sold a total of 26,000 shares of company stock valued at $2,309,200 over the last 90 days. Corporate insiders own 16.60% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. lifted its holdings in shares of Masimo Corporation by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 4,997 shares of the medical equipment provider’s stock valued at $456,000 after buying an additional 13 shares during the last quarter. Sterling Capital Management LLC lifted its holdings in shares of Masimo Corporation by 0.6% during the 2nd quarter. Sterling Capital Management LLC now owns 7,803 shares of the medical equipment provider’s stock valued at $711,000 after buying an additional 44 shares during the last quarter. Ifrah Financial Services Inc. lifted its holdings in shares of Masimo Corporation by 1.2% during the 2nd quarter. Ifrah Financial Services Inc. now owns 4,564 shares of the medical equipment provider’s stock valued at $416,000 after buying an additional 53 shares during the last quarter. Hanseatic Management Services Inc. lifted its holdings in shares of Masimo Corporation by 1.1% during the 2nd quarter. Hanseatic Management Services Inc. now owns 5,273 shares of the medical equipment provider’s stock valued at $481,000 after buying an additional 58 shares during the last quarter. Finally, Dubuque Bank & Trust Co. lifted its holdings in shares of Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 61 shares during the last quarter. Institutional investors and hedge funds own 82.96% of the company’s stock.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.